NCT00019994View on ClinicalTrials.gov

Vaccine Therapy in Treating Patients With Metastatic Melanoma

PHASE2CompletedINTERVENTIONAL

Timeline

Start Date

October 31, 1999

Study Completion Date

October 31, 2007

Conditions

Melanoma (Skin)

Interventions

BIOLOGICAL

MART-1 antigen

BIOLOGICAL

aldesleukin

BIOLOGICAL

gp100 antigen

BIOLOGICAL

incomplete Freund's adjuvant

Trial Locations (1)

20892-1182

Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support, Bethesda

All Listed Sponsors

lead

National Cancer Institute (NCI)

NIH